Back to Authors

Rizvi, Syed

https://orcid.org/0009-0000-0081-0239

A5101668954 | I867280407

Mayo Clinic

The University of Texas Southwestern Medical Center

Citations 1

ENGINE: A Phase III Randomized Placebo Controlled Study of Enzastaurin/R-CHOP as Frontline Therapy in High-Risk Diffuse Large B-Cell Lymphoma Patients with the Genomic Biomarker DGM1

Future Oncology | April 6, 2020 | Volume: 16 | Issue: 15 | Pages: 991-999

10.2217/fon-2020-0176 | PMID 32250167